MedPath

Tenormin®

Brand Name: Tenormin®

Generic Name: Atenolol

Active
Registration Number

DR-XY14043

Dosage Form

Tablet

Issuance Date

July 2, 2024

Expiry Date

July 2, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg
PackagingAlu-PVC Blister Pack x 14's (Box of 98's)

Classification

C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Selective Beta-adrenoceptor Blocker
A
Application
Initial (Variation)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

AtenololActive
Monograph: Atenolol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform